Cargando…

A Multi-Analyte Approach for Improved Sensitivity of Liquid Biopsies in Prostate Cancer

Novel androgen receptor (AR) signaling inhibitors have improved the treatment of castration-resistant prostate cancer (CRPC). Nonetheless, the effect of these drugs is often time-limited and eventually most patients become resistant due to various AR alterations. Although liquid biopsy approaches ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofmann, Lilli, Sallinger, Katja, Haudum, Christoph, Smolle, Maria, Heitzer, Ellen, Moser, Tina, Novy, Michael, Gesson, Kevin, Kroneis, Thomas, Bauernhofer, Thomas, El-Heliebi, Amin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465186/ https://www.ncbi.nlm.nih.gov/pubmed/32796730 http://dx.doi.org/10.3390/cancers12082247

Ejemplares similares

Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse
por: Sallinger, Katja, et al.
Publicado: (2023)

Unravelling the biological secrets of microchimerism by single-cell analysis
por: Ståhlberg, Anders, et al.
Publicado: (2017)

The potential of liquid biopsies for the early detection of cancer
por: Heitzer, Ellen, et al.
Publicado: (2017)

Maternal COVID-19 causing intrauterine foetal demise with microthrombotic placental insufficiency: a case report
por: Nonn, Olivia, et al.
Publicado: (2023)

Circulating tumor cells and DNA as liquid biopsies
por: Heitzer, Ellen, et al.
Publicado: (2013)

Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents
por: Seidel, Markus G., et al.
Publicado: (2022)

Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer
por: Smolle, Maria A., et al.
Publicado: (2017)

Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer
por: Smolle, Elisabeth, et al.
Publicado: (2020)

Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
por: Chen, Shukun, et al.
Publicado: (2018)

In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy
por: Chen, Shukun, et al.
Publicado: (2019)

A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study
por: Unseld, Matthias, et al.
Publicado: (2020)

Resolving Tumor Heterogeneity: Genes Involved in Chordoma Cell Development Identified by Low-Template Analysis of Morphologically Distinct Cells
por: El-Heliebi, Amin, et al.
Publicado: (2014)

Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
por: Ulz, Peter, et al.
Publicado: (2016)

Liquid biopsy in non-small cell lung cancer—current status and future outlook—a narrative review
por: Smolle, Elisabeth, et al.
Publicado: (2021)

Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?
por: El-Heliebi, Amin, et al.
Publicado: (2013)

Liquid Biopsy Potential Biomarkers in Prostate Cancer
por: Neuhaus, Jochen, et al.
Publicado: (2018)

The Role of Liquid Biopsy Analytes in Diagnosis, Treatment and Prognosis of Colorectal Cancer
por: He, JinHua, et al.
Publicado: (2022)

Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide
por: Belic, Jelena, et al.
Publicado: (2018)

Evaluating liquid biopsies for methylomic profiling of prostate cancer
por: Silva, Romina, et al.
Publicado: (2020)

Vibrational spectroscopy of liquid biopsies for prostate cancer diagnosis
por: Medipally, Dinesh K. R., et al.
Publicado: (2020)

Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer
por: Jang, Albert, et al.
Publicado: (2022)

Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
por: Kim, Yunee, et al.
Publicado: (2016)

Catch and Release: rare cell analysis from a functionalised medical wire
por: Chen, Shukun, et al.
Publicado: (2017)

Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer
por: Keup, Corinna, et al.
Publicado: (2021)

Evaluating Pre-Analytical Variables for Saliva Cell-Free DNA Liquid Biopsy
por: Salfer, Blake, et al.
Publicado: (2023)

Evaluation of an RNAseq-Based Immunogenomic Liquid Biopsy Approach in Early-Stage Prostate Cancer
por: Van Neste, Leander, et al.
Publicado: (2021)

Current status of liquid biopsies for the detection and management of prostate cancer
por: Lu, Yi-Tsung, et al.
Publicado: (2019)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

Liquid Biopsy in Diagnosis and Prognosis of Non-Metastatic Prostate Cancer
por: Rzhevskiy, Alexey S., et al.
Publicado: (2022)

Current advances of liquid biopsies in prostate cancer: Molecular biomarkers
por: Alahdal, Murad, et al.
Publicado: (2023)

Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy
por: Sato, Akemi, et al.
Publicado: (2018)

Non-invasive lung cancer diagnosis and prognosis based on multi-analyte liquid biopsy
por: Chen, Kezhong, et al.
Publicado: (2021)

Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
por: Di Nunno, Vincenzo, et al.
Publicado: (2018)

Liquid Biopsy in Oligometastatic Prostate Cancer—A Biologist's Point of View
por: Stelcer, Ewelina, et al.
Publicado: (2019)

Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
por: Matuszczak, Milena, et al.
Publicado: (2021)

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
por: Trujillo, Blanca, et al.
Publicado: (2022)

Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives
por: Crocetto, Felice, et al.
Publicado: (2022)

Evolving insights in blood-based liquid biopsies for prostate cancer interrogation
por: Bonfil, R. Daniel, et al.
Publicado: (2023)

Liquid Biopsy Preservation Solutions for Standardized Pre-Analytical Workflows—Venous Whole Blood and Plasma
por: Grölz, Daniel, et al.
Publicado: (2018)

Molecular profiling of soft-tissue sarcomas with FoundationOne(®) Heme identifies potential targets for sarcoma therapy: a single-centre experience
por: Scheipl, Susanne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gjlfmd45iahgdm3sdlafinprf0